Summary & Overview
HCPCS Level II J1098: Articaine Ophthalmic 8% Solution, 0.4 ml
HCPCS Level II code J1098 denotes articaine ophthalmic, 8% solution, 0.4 ml — a high-concentration local anesthetic formulation used in ophthalmic procedures. This code identifies a specific drug product supplied for ocular anesthesia and is relevant for billing of perioperative and procedural anesthesia in ophthalmology. Nationally, precise HCPCS coding for ophthalmic anesthetics matters for accurate claims processing, inventory management, and clinical documentation.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of use, along with billing benchmarks where available, common policy considerations for drug-product HCPCS codes, and coding comparators. The publication summarizes service-line implications for ambulatory ophthalmology and outpatient surgical centers and outlines areas where payers commonly apply separate drug administration or supply rules. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1098 represents articaine ophthalmic, 8% solution, 0.4 ml. This code describes a concentrated local anesthetic formulation specifically intended for ophthalmic use. The service type is ophthalmic local anesthesia administration/device and the typical site of service is ambulatory ophthalmology settings or outpatient surgical centers where ocular procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an ophthalmology clinic or ambulatory surgery center for a minor anterior segment procedure such as foreign body removal, corneal debridement, or a diagnostic slit-lamp procedure requiring topical ocular anesthesia. The patient reports focal ocular pain, foreign body sensation, or planned superficial corneal manipulation. After informed consent, the patient is positioned at the slit lamp or procedure chair. The clinician instills topical antiseptic (if indicated), then administers one drop or a microinjection of Articaine ophthalmic, 8% solution, 0.4 ml to the conjunctival sac to provide rapid onset topical anesthesia of the cornea and conjunctiva. The clinician performs the procedure (e.g., foreign body removal, superficial corneal scraping, or minor anterior chamber manipulation) while monitoring patient comfort and ocular surface response. Post-procedure, the clinician documents the medication used (including J1098), lot number, volume, response, and any immediate adverse events, provides aftercare instructions, and schedules follow-up as appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is provided on the same day as topical ophthalmic medication administration for a procedure. |